Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021
-
Published:2023-05
Issue:
Volume:59
Page:101966
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Bai Lin,
Zhan Yuqi,
Zhou Yue,
Zhang Yichen,
Shi Luwen,
Gupta Sumit,
Denburg Avram,
Guan XiaodongORCID
Reference30 articles.
1. Estimating the total incidence of global childhood cancer: a simulation-based analysis;Ward;Lancet Oncol,2019
2. National, regional, and global causes of mortality in 5-19-year-olds from 2000 to 2019: a systematic analysis;Liu;Lancet Global Health,2022
3. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol,2017
4. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge;Rodriguez-Galindo;J Clin Oncol,2015
5. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries;Ssenyonga;Lancet Child Adolescent Health,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献